Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.52608506 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.52608506 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.14794346 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.14794346 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.76753832 |
6 | tryptophan catabolic process (GO:0006569) | 5.09608060 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.09608060 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.09608060 |
9 | bile acid biosynthetic process (GO:0006699) | 4.82848984 |
10 | tryptophan metabolic process (GO:0006568) | 4.77058603 |
11 | glyoxylate metabolic process (GO:0046487) | 4.75520221 |
12 | fatty acid elongation (GO:0030497) | 4.64162147 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.55453549 |
14 | kynurenine metabolic process (GO:0070189) | 4.51770594 |
15 | mannose metabolic process (GO:0006013) | 4.31539795 |
16 | coenzyme catabolic process (GO:0009109) | 4.21282548 |
17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.20573783 |
18 | protein carboxylation (GO:0018214) | 4.19193711 |
19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.19193711 |
20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13996523 |
21 | aromatic amino acid family metabolic process (GO:0009072) | 4.12708656 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09911513 |
23 | bile acid metabolic process (GO:0008206) | 4.09359282 |
24 | cellular biogenic amine catabolic process (GO:0042402) | 4.06471389 |
25 | amine catabolic process (GO:0009310) | 4.06471389 |
26 | urea metabolic process (GO:0019627) | 3.96425590 |
27 | urea cycle (GO:0000050) | 3.96425590 |
28 | sulfur amino acid catabolic process (GO:0000098) | 3.94310483 |
29 | regulation of cholesterol esterification (GO:0010872) | 3.92334466 |
30 | aldehyde catabolic process (GO:0046185) | 3.91398625 |
31 | tyrosine metabolic process (GO:0006570) | 3.90758585 |
32 | regulation of triglyceride catabolic process (GO:0010896) | 3.79475776 |
33 | nitrogen cycle metabolic process (GO:0071941) | 3.79250586 |
34 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77402449 |
35 | cofactor catabolic process (GO:0051187) | 3.76694076 |
36 | complement activation, alternative pathway (GO:0006957) | 3.75265667 |
37 | axon ensheathment in central nervous system (GO:0032291) | 3.73950033 |
38 | central nervous system myelination (GO:0022010) | 3.73950033 |
39 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72870307 |
40 | protein-lipid complex remodeling (GO:0034368) | 3.72870307 |
41 | macromolecular complex remodeling (GO:0034367) | 3.72870307 |
42 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.72762030 |
43 | alpha-amino acid catabolic process (GO:1901606) | 3.65680617 |
44 | cellular ketone body metabolic process (GO:0046950) | 3.65535650 |
45 | short-chain fatty acid metabolic process (GO:0046459) | 3.65530966 |
46 | very long-chain fatty acid metabolic process (GO:0000038) | 3.63771486 |
47 | regulation of fibrinolysis (GO:0051917) | 3.63248043 |
48 | reverse cholesterol transport (GO:0043691) | 3.63172663 |
49 | indolalkylamine metabolic process (GO:0006586) | 3.61550159 |
50 | regulation of protein activation cascade (GO:2000257) | 3.59508591 |
51 | cysteine metabolic process (GO:0006534) | 3.55862955 |
52 | amino-acid betaine metabolic process (GO:0006577) | 3.55184362 |
53 | cholesterol biosynthetic process (GO:0006695) | 3.49984614 |
54 | negative regulation of fibrinolysis (GO:0051918) | 3.48640018 |
55 | acetyl-CoA metabolic process (GO:0006084) | 3.47709795 |
56 | homocysteine metabolic process (GO:0050667) | 3.46415444 |
57 | nucleotide transmembrane transport (GO:1901679) | 3.42382019 |
58 | triglyceride homeostasis (GO:0070328) | 3.40531295 |
59 | acylglycerol homeostasis (GO:0055090) | 3.40531295 |
60 | cellular amino acid catabolic process (GO:0009063) | 3.40026413 |
61 | * plasma lipoprotein particle clearance (GO:0034381) | 3.38911858 |
62 | fatty acid beta-oxidation (GO:0006635) | 3.38641620 |
63 | cholesterol efflux (GO:0033344) | 3.37159881 |
64 | phospholipid efflux (GO:0033700) | 3.35732312 |
65 | NAD biosynthetic process (GO:0009435) | 3.34888792 |
66 | regulation of complement activation (GO:0030449) | 3.34387223 |
67 | opsonization (GO:0008228) | 3.30196214 |
68 | fatty acid catabolic process (GO:0009062) | 3.28526527 |
69 | regulation of ARF GTPase activity (GO:0032312) | 3.28260965 |
70 | monocarboxylic acid catabolic process (GO:0072329) | 3.23780870 |
71 | branched-chain amino acid catabolic process (GO:0009083) | 3.23259430 |
72 | organic acid catabolic process (GO:0016054) | 3.22569128 |
73 | carboxylic acid catabolic process (GO:0046395) | 3.22569128 |
74 | valine metabolic process (GO:0006573) | 3.22244329 |
75 | ketone body metabolic process (GO:1902224) | 3.21993326 |
76 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21951655 |
77 | fatty acid oxidation (GO:0019395) | 3.21061020 |
78 | negative regulation of cell size (GO:0045792) | 3.19909170 |
79 | lipid oxidation (GO:0034440) | 3.19229700 |
80 | chondroitin sulfate catabolic process (GO:0030207) | 3.18016770 |
81 | cellular modified amino acid catabolic process (GO:0042219) | 3.15720982 |
82 | endothelial cell chemotaxis (GO:0035767) | 3.15617932 |
83 | negative regulation of lipase activity (GO:0060192) | 3.15596100 |
84 | acyl-CoA metabolic process (GO:0006637) | 3.11139973 |
85 | thioester metabolic process (GO:0035383) | 3.11139973 |
86 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.09591395 |
87 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.09591395 |
88 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.09295640 |
89 | aspartate family amino acid catabolic process (GO:0009068) | 3.09057729 |
90 | sterol biosynthetic process (GO:0016126) | 3.07921413 |
91 | bile acid and bile salt transport (GO:0015721) | 3.07351811 |
92 | serine family amino acid catabolic process (GO:0009071) | 3.05611316 |
93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.03771266 |
94 | negative regulation of sterol transport (GO:0032372) | 3.03511223 |
95 | negative regulation of cholesterol transport (GO:0032375) | 3.03511223 |
96 | ethanol oxidation (GO:0006069) | 3.03009975 |
97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.01921032 |
98 | serine family amino acid biosynthetic process (GO:0009070) | 3.01022928 |
99 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.00462599 |
100 | protein activation cascade (GO:0072376) | 2.99531320 |
101 | synaptic vesicle exocytosis (GO:0016079) | 2.99241258 |
102 | negative regulation of cell killing (GO:0031342) | 2.98725564 |
103 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.98725564 |
104 | heme transport (GO:0015886) | 2.97902726 |
105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.97031164 |
106 | complement activation, classical pathway (GO:0006958) | 2.96780175 |
107 | fibrinolysis (GO:0042730) | 2.96554598 |
108 | negative regulation of receptor activity (GO:2000272) | 2.95992023 |
109 | branched-chain amino acid metabolic process (GO:0009081) | 2.95026522 |
110 | cholesterol homeostasis (GO:0042632) | 2.94922231 |
111 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.94748109 |
112 | drug transmembrane transport (GO:0006855) | 2.94243793 |
113 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.78946755 |
114 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.78804830 |
115 | regulation of ARF protein signal transduction (GO:0032012) | 2.69074816 |
116 | growth hormone secretion (GO:0030252) | 2.64982800 |
117 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.63635632 |
118 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.63206128 |
119 | positive regulation of protein kinase C signaling (GO:0090037) | 2.61025916 |
120 | regulation of extracellular matrix disassembly (GO:0010715) | 2.54292498 |
121 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.53861178 |
122 | dermatan sulfate metabolic process (GO:0030205) | 2.45391780 |
123 | positive regulation of histone deacetylation (GO:0031065) | 2.45130123 |
124 | amyloid precursor protein catabolic process (GO:0042987) | 2.44684553 |
125 | negative regulation of granulocyte differentiation (GO:0030853) | 2.44662428 |
126 | cell-cell junction maintenance (GO:0045217) | 2.44482940 |
127 | sulfur compound catabolic process (GO:0044273) | 2.43627625 |
128 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.42295052 |
129 | barbed-end actin filament capping (GO:0051016) | 2.41892361 |
130 | protein retention in ER lumen (GO:0006621) | 2.39796930 |
131 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.39336798 |
132 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.37745605 |
133 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.37229018 |
134 | purine nucleotide salvage (GO:0032261) | 2.31832412 |
135 | positive thymic T cell selection (GO:0045059) | 2.31103194 |
136 | semaphorin-plexin signaling pathway (GO:0071526) | 2.27667468 |
137 | neuronal ion channel clustering (GO:0045161) | 2.25794506 |
138 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.25665008 |
139 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.25440268 |
140 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.24929364 |
141 | tolerance induction (GO:0002507) | 2.24604984 |
142 | lytic vacuole organization (GO:0080171) | 2.22934110 |
143 | lysosome organization (GO:0007040) | 2.22934110 |
144 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.22790129 |
145 | thymic T cell selection (GO:0045061) | 2.21068891 |
146 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.20840725 |
147 | synaptic vesicle endocytosis (GO:0048488) | 2.18359272 |
148 | adhesion of symbiont to host (GO:0044406) | 2.16667493 |
149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.16228267 |
150 | regulation of plasminogen activation (GO:0010755) | 2.15009477 |
151 | establishment of mitochondrion localization (GO:0051654) | 2.14048960 |
152 | negative regulation of interleukin-2 production (GO:0032703) | 2.13904713 |
153 | cellular response to exogenous dsRNA (GO:0071360) | 2.13489362 |
154 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.13078652 |
155 | virion attachment to host cell (GO:0019062) | 2.12880857 |
156 | adhesion of symbiont to host cell (GO:0044650) | 2.12880857 |
157 | regulation of cholesterol storage (GO:0010885) | 2.12760042 |
158 | histone H4 deacetylation (GO:0070933) | 2.11697836 |
159 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.11318237 |
160 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.10273285 |
161 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.09889750 |
162 | protein heterotrimerization (GO:0070208) | 2.09781260 |
163 | negative regulation of innate immune response (GO:0045824) | 2.07139006 |
164 | stress fiber assembly (GO:0043149) | 2.06229689 |
165 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.06068970 |
166 | positive regulation of receptor recycling (GO:0001921) | 2.05538004 |
167 | cell migration involved in heart development (GO:0060973) | 2.05244735 |
168 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.04752911 |
169 | positive regulation of cholesterol efflux (GO:0010875) | 2.03304650 |
170 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.02690265 |
171 | amyloid precursor protein metabolic process (GO:0042982) | 2.01870007 |
172 | regulation of histone deacetylation (GO:0031063) | 2.01627203 |
173 | response to magnesium ion (GO:0032026) | 2.01227335 |
174 | regulation of gamma-delta T cell activation (GO:0046643) | 2.01068350 |
175 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.00194127 |
176 | positive regulation of extracellular matrix organization (GO:1903055) | 1.99632703 |
177 | behavioral response to pain (GO:0048266) | 1.99295907 |
178 | extracellular matrix assembly (GO:0085029) | 1.99196947 |
179 | response to muramyl dipeptide (GO:0032495) | 1.98931624 |
180 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.98580463 |
181 | layer formation in cerebral cortex (GO:0021819) | 1.98002939 |
182 | activation of JUN kinase activity (GO:0007257) | 1.96240114 |
183 | vacuole organization (GO:0007033) | 1.94873654 |
184 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.92457713 |
185 | * regulation of cholesterol metabolic process (GO:0090181) | 1.92228234 |
186 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 1.91943619 |
187 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 1.91309130 |
188 | glial cell migration (GO:0008347) | 1.90723069 |
189 | response to manganese ion (GO:0010042) | 1.90469629 |
190 | deoxyribonucleotide catabolic process (GO:0009264) | 1.88996201 |
191 | T cell selection (GO:0045058) | 1.88295010 |
192 | negative regulation of myotube differentiation (GO:0010832) | 1.88152854 |
193 | positive regulation of endothelial cell differentiation (GO:0045603) | 1.88092808 |
194 | snRNA transcription (GO:0009301) | 1.88067992 |
195 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 1.87933067 |
196 | response to methylmercury (GO:0051597) | 1.87084805 |
197 | dermatan sulfate biosynthetic process (GO:0030208) | 1.86702864 |
198 | autophagic vacuole assembly (GO:0000045) | 1.86627696 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.34242550 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16735938 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.03019855 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.37819266 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25751969 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.91646897 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.26533960 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.18098705 |
9 | * LXR_22292898_ChIP-Seq_THP-1_Human | 3.05476499 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67258766 |
11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.61117421 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.52170491 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51164959 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46053382 |
15 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.42329004 |
16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37049957 |
17 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.36324680 |
18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.18398255 |
19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.16166205 |
20 | P68_20966046_ChIP-Seq_HELA_Human | 2.12717674 |
21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05175329 |
22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02231355 |
23 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.01429920 |
24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.99273952 |
25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98784785 |
26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92272281 |
27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.91931506 |
28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89771076 |
29 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.83819282 |
30 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.80422448 |
31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.77808719 |
32 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.76458800 |
33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76281162 |
34 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.74395116 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.73164781 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72847213 |
37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71782474 |
38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70107823 |
39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.69732881 |
40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.68498668 |
41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.66748081 |
42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66470056 |
43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.64929640 |
44 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.64864901 |
45 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.60389860 |
46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59830597 |
47 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58759107 |
48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57670456 |
49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.56348094 |
50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54897582 |
51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52980573 |
52 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51111130 |
53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43572400 |
54 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.43306437 |
55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43168493 |
56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42900554 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42773989 |
58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42216782 |
59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41186589 |
60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39161489 |
61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38346495 |
62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38148803 |
63 | MAF_26560356_Chip-Seq_TH2_Human | 1.37657082 |
64 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35977667 |
65 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35185086 |
66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34824810 |
67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34798712 |
68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34657539 |
69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34087712 |
70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32088467 |
71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32044949 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31064882 |
73 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30608262 |
74 | MYC_22102868_ChIP-Seq_BL_Human | 1.29966429 |
75 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.28392274 |
76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.28058733 |
77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27923016 |
78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27542590 |
79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24453542 |
80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23875984 |
81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23416529 |
82 | MAF_26560356_Chip-Seq_TH1_Human | 1.23365512 |
83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23175435 |
84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22708195 |
85 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.20346316 |
86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19609235 |
87 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19350122 |
88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.18402977 |
89 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18087499 |
90 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17149768 |
91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16847531 |
92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16842982 |
93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16511454 |
94 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16052355 |
95 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14987093 |
96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14106665 |
97 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.13705652 |
98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12573471 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12412379 |
100 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12093566 |
101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11897828 |
102 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11831795 |
103 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11774788 |
104 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11116026 |
105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10872578 |
106 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10421034 |
107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10209981 |
108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09069402 |
109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08939158 |
110 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08349899 |
111 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.08347927 |
112 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.07981407 |
113 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07604985 |
114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07083387 |
115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06684896 |
116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06197262 |
117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05884659 |
118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04887910 |
119 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04456631 |
120 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03965335 |
121 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03804899 |
122 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03762107 |
123 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03679195 |
124 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.02464113 |
125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01027299 |
126 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00715268 |
127 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00000130 |
128 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99673210 |
129 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99434462 |
130 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.99317711 |
131 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99301111 |
132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99259070 |
133 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98810218 |
134 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98303454 |
135 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.98096440 |
136 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97928096 |
137 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97837483 |
138 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97560594 |
139 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97346922 |
140 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97219687 |
141 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95854621 |
142 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95269838 |
143 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94063257 |
144 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93420542 |
145 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93416683 |
146 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91480498 |
147 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91002485 |
148 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.89770474 |
149 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89643154 |
150 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88259046 |
151 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87617944 |
152 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87617944 |
153 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86893934 |
154 | CBP_21632823_ChIP-Seq_H3396_Human | 0.86725965 |
155 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86418823 |
156 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.86259402 |
157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86239365 |
158 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85239221 |
159 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.83507760 |
160 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.81929153 |
161 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81293649 |
162 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80808187 |
163 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.80796944 |
164 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80539601 |
165 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80225442 |
166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79570077 |
167 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.79409267 |
168 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.79331851 |
169 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.78861990 |
170 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.78673100 |
171 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.78369226 |
172 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77840750 |
173 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77744512 |
174 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.77612703 |
175 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.77101549 |
176 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.76351890 |
177 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.75834073 |
178 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75112682 |
179 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74699566 |
180 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.72590163 |
181 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71993513 |
182 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71909861 |
183 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71909861 |
184 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.71431219 |
185 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.71139753 |
186 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70776501 |
187 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.70366822 |
188 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69598888 |
189 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.69528330 |
190 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69336092 |
191 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.68990715 |
192 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.68806140 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.48531079 |
2 | MP0005360_urolithiasis | 5.59882523 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.11226576 |
4 | MP0005365_abnormal_bile_salt | 5.06056335 |
5 | MP0003806_abnormal_nucleotide_metabolis | 4.23921807 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89185380 |
7 | MP0003252_abnormal_bile_duct | 3.11296000 |
8 | MP0003195_calcinosis | 3.10894019 |
9 | MP0003705_abnormal_hypodermis_morpholog | 2.78468574 |
10 | MP0005083_abnormal_biliary_tract | 2.59343469 |
11 | MP0009840_abnormal_foam_cell | 2.52920800 |
12 | MP0003279_aneurysm | 2.48001069 |
13 | MP0005332_abnormal_amino_acid | 2.45551495 |
14 | MP0010329_abnormal_lipoprotein_level | 2.44726625 |
15 | MP0001958_emphysema | 2.42153524 |
16 | MP0004859_abnormal_synaptic_plasticity | 2.36046395 |
17 | MP0001666_abnormal_nutrient_absorption | 2.35999164 |
18 | MP0000920_abnormal_myelination | 2.24758038 |
19 | MP0003436_decreased_susceptibility_to | 2.21159869 |
20 | MP0009697_abnormal_copulation | 2.20971445 |
21 | MP0005451_abnormal_body_composition | 2.02644625 |
22 | MP0002653_abnormal_ependyma_morphology | 1.98484749 |
23 | * MP0002118_abnormal_lipid_homeostasis | 1.97874090 |
24 | MP0003690_abnormal_glial_cell | 1.93338968 |
25 | MP0005503_abnormal_tendon_morphology | 1.90406103 |
26 | MP0005670_abnormal_white_adipose | 1.84080223 |
27 | MP0005410_abnormal_fertilization | 1.83976697 |
28 | MP0008260_abnormal_autophagy | 1.79606091 |
29 | MP0003191_abnormal_cellular_cholesterol | 1.78458312 |
30 | MP0009278_abnormal_bone_marrow | 1.75392873 |
31 | MP0004858_abnormal_nervous_system | 1.70197732 |
32 | MP0004019_abnormal_vitamin_homeostasis | 1.65950118 |
33 | MP0003868_abnormal_feces_composition | 1.63471411 |
34 | MP0000751_myopathy | 1.63376563 |
35 | MP0003011_delayed_dark_adaptation | 1.59762235 |
36 | MP0006082_CNS_inflammation | 1.53354379 |
37 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.53304616 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.52703959 |
39 | MP0000609_abnormal_liver_physiology | 1.52211364 |
40 | MP0003303_peritoneal_inflammation | 1.51166329 |
41 | MP0001849_ear_inflammation | 1.50253910 |
42 | MP0005058_abnormal_lysosome_morphology | 1.45989981 |
43 | MP0001764_abnormal_homeostasis | 1.42851502 |
44 | MP0005423_abnormal_somatic_nervous | 1.40864443 |
45 | MP0003879_abnormal_hair_cell | 1.40402093 |
46 | MP0005319_abnormal_enzyme/_coenzyme | 1.36523025 |
47 | MP0009764_decreased_sensitivity_to | 1.34973068 |
48 | MP0003136_yellow_coat_color | 1.29403510 |
49 | MP0001533_abnormal_skeleton_physiology | 1.28691256 |
50 | MP0004381_abnormal_hair_follicle | 1.23311478 |
51 | MP0003186_abnormal_redox_activity | 1.23073086 |
52 | MP0003724_increased_susceptibility_to | 1.22995717 |
53 | MP0005171_absent_coat_pigmentation | 1.22851450 |
54 | MP0009643_abnormal_urine_homeostasis | 1.21456131 |
55 | MP0004947_skin_inflammation | 1.16840076 |
56 | MP0000566_synostosis | 1.16352023 |
57 | MP0005408_hypopigmentation | 1.14913117 |
58 | MP0000013_abnormal_adipose_tissue | 1.14407273 |
59 | MP0001542_abnormal_bone_strength | 1.11630085 |
60 | MP0005647_abnormal_sex_gland | 1.10702619 |
61 | MP0008874_decreased_physiological_sensi | 1.09606058 |
62 | MP0002876_abnormal_thyroid_physiology | 1.08176111 |
63 | MP0002132_abnormal_respiratory_system | 1.07943907 |
64 | MP0005595_abnormal_vascular_smooth | 1.07918221 |
65 | MP0000767_abnormal_smooth_muscle | 1.06275780 |
66 | MP0005390_skeleton_phenotype | 1.05752195 |
67 | MP0003656_abnormal_erythrocyte_physiolo | 1.05019450 |
68 | MP0002249_abnormal_larynx_morphology | 1.04543355 |
69 | MP0001502_abnormal_circadian_rhythm | 1.04108441 |
70 | MP0000604_amyloidosis | 1.03385065 |
71 | MP0008569_lethality_at_weaning | 1.03179463 |
72 | MP0003635_abnormal_synaptic_transmissio | 1.02921254 |
73 | MP0005000_abnormal_immune_tolerance | 1.02838934 |
74 | MP0003763_abnormal_thymus_physiology | 1.02741184 |
75 | MP0003091_abnormal_cell_migration | 1.02392502 |
76 | MP0003300_gastrointestinal_ulcer | 0.99753365 |
77 | MP0009763_increased_sensitivity_to | 0.99496865 |
78 | MP0008469_abnormal_protein_level | 0.98694488 |
79 | MP0000003_abnormal_adipose_tissue | 0.98509888 |
80 | MP0002063_abnormal_learning/memory/cond | 0.97218004 |
81 | MP0000465_gastrointestinal_hemorrhage | 0.96940927 |
82 | MP0005636_abnormal_mineral_homeostasis | 0.96831853 |
83 | MP0005508_abnormal_skeleton_morphology | 0.94276329 |
84 | MP0003878_abnormal_ear_physiology | 0.94091706 |
85 | MP0005377_hearing/vestibular/ear_phenot | 0.94091706 |
86 | MP0002822_catalepsy | 0.93759153 |
87 | * MP0002295_abnormal_pulmonary_circulatio | 0.93723756 |
88 | MP0002998_abnormal_bone_remodeling | 0.91463345 |
89 | MP0002064_seizures | 0.90713887 |
90 | MP0002419_abnormal_innate_immunity | 0.88949983 |
91 | MP0006036_abnormal_mitochondrial_physio | 0.88890789 |
92 | MP0009765_abnormal_xenobiotic_induced | 0.88753255 |
93 | MP0002735_abnormal_chemical_nociception | 0.86414466 |
94 | MP0004133_heterotaxia | 0.85720945 |
95 | MP0001851_eye_inflammation | 0.85492884 |
96 | MP0004142_abnormal_muscle_tone | 0.85370881 |
97 | MP0000678_abnormal_parathyroid_gland | 0.85279687 |
98 | MP0005275_abnormal_skin_tensile | 0.84491648 |
99 | MP0001800_abnormal_humoral_immune | 0.84319919 |
100 | MP0001661_extended_life_span | 0.83770160 |
101 | MP0003950_abnormal_plasma_membrane | 0.83703149 |
102 | MP0002723_abnormal_immune_serum | 0.82625570 |
103 | MP0001486_abnormal_startle_reflex | 0.82467235 |
104 | MP0004742_abnormal_vestibular_system | 0.81059911 |
105 | MP0004147_increased_porphyrin_level | 0.80987939 |
106 | MP0001986_abnormal_taste_sensitivity | 0.79179687 |
107 | MP0001873_stomach_inflammation | 0.77231764 |
108 | MP0005671_abnormal_response_to | 0.76918571 |
109 | * MP0009642_abnormal_blood_homeostasis | 0.76607218 |
110 | MP0000026_abnormal_inner_ear | 0.75555973 |
111 | MP0002108_abnormal_muscle_morphology | 0.75028551 |
112 | MP0003633_abnormal_nervous_system | 0.74405360 |
113 | MP0000733_abnormal_muscle_development | 0.74082418 |
114 | MP0000750_abnormal_muscle_regeneration | 0.74078393 |
115 | MP0004130_abnormal_muscle_cell | 0.73630947 |
116 | MP0000598_abnormal_liver_morphology | 0.72459225 |
117 | MP0002148_abnormal_hypersensitivity_rea | 0.72023762 |
118 | MP0004510_myositis | 0.71967638 |
119 | MP0004043_abnormal_pH_regulation | 0.71385209 |
120 | MP0000858_altered_metastatic_potential | 0.71370045 |
121 | MP0005535_abnormal_body_temperature | 0.71358625 |
122 | MP0009384_cardiac_valve_regurgitation | 0.70456997 |
123 | MP0005220_abnormal_exocrine_pancreas | 0.69944717 |
124 | MP0002572_abnormal_emotion/affect_behav | 0.69653170 |
125 | MP0002452_abnormal_antigen_presenting | 0.68772220 |
126 | MP0003329_amyloid_beta_deposits | 0.68754550 |
127 | MP0002089_abnormal_postnatal_growth/wei | 0.68446647 |
128 | MP0001270_distended_abdomen | 0.68387604 |
129 | MP0000747_muscle_weakness | 0.68256046 |
130 | MP0001963_abnormal_hearing_physiology | 0.67575524 |
131 | MP0005334_abnormal_fat_pad | 0.67197526 |
132 | MP0010368_abnormal_lymphatic_system | 0.66612492 |
133 | MP0005167_abnormal_blood-brain_barrier | 0.66508340 |
134 | MP0005084_abnormal_gallbladder_morpholo | 0.65780081 |
135 | MP0002420_abnormal_adaptive_immunity | 0.65439035 |
136 | MP0001819_abnormal_immune_cell | 0.65305131 |
137 | MP0002405_respiratory_system_inflammati | 0.64797489 |
138 | MP0005025_abnormal_response_to | 0.64439861 |
139 | MP0005379_endocrine/exocrine_gland_phen | 0.64051489 |
140 | MP0001835_abnormal_antigen_presentation | 0.63836878 |
141 | MP0005376_homeostasis/metabolism_phenot | 0.63578494 |
142 | MP0009785_altered_susceptibility_to | 0.63365517 |
143 | MP0005075_abnormal_melanosome_morpholog | 0.63201991 |
144 | MP0005646_abnormal_pituitary_gland | 0.62936914 |
145 | MP0002078_abnormal_glucose_homeostasis | 0.61953279 |
146 | MP0000749_muscle_degeneration | 0.61817244 |
147 | MP0002933_joint_inflammation | 0.60258873 |
148 | MP0005666_abnormal_adipose_tissue | 0.59615956 |
149 | MP0000372_irregular_coat_pigmentation | 0.59502978 |
150 | MP0003634_abnormal_glial_cell | 0.57679055 |
151 | MP0001905_abnormal_dopamine_level | 0.56069228 |
152 | MP0003172_abnormal_lysosome_physiology | 0.55930286 |
153 | MP0000230_abnormal_systemic_arterial | 0.55353658 |
154 | MP0001765_abnormal_ion_homeostasis | 0.54757752 |
155 | MP0000639_abnormal_adrenal_gland | 0.54499721 |
156 | MP0002229_neurodegeneration | 0.53680995 |
157 | MP0002971_abnormal_brown_adipose | 0.53535099 |
158 | MP0004782_abnormal_surfactant_physiolog | 0.53206566 |
159 | MP0004134_abnormal_chest_morphology | 0.52892819 |
160 | MP0005464_abnormal_platelet_physiology | 0.52707284 |
161 | MP0001485_abnormal_pinna_reflex | 0.52486264 |
162 | MP0008438_abnormal_cutaneous_collagen | 0.52313963 |
163 | MP0003075_altered_response_to | 0.51624951 |
164 | MP0005551_abnormal_eye_electrophysiolog | 0.51619470 |
165 | MP0003183_abnormal_peptide_metabolism | 0.50041145 |
166 | MP0005387_immune_system_phenotype | 0.49380642 |
167 | MP0001790_abnormal_immune_system | 0.49380642 |
168 | MP0001845_abnormal_inflammatory_respons | 0.49074310 |
169 | MP0001324_abnormal_eye_pigmentation | 0.47174398 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.81380881 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.48596266 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 5.35862852 |
4 | Deep venous thrombosis (HP:0002625) | 4.68772919 |
5 | Xanthomatosis (HP:0000991) | 4.46413919 |
6 | Hyperlipoproteinemia (HP:0010980) | 4.41866718 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.13711819 |
8 | Joint hemorrhage (HP:0005261) | 4.02046619 |
9 | Dysostosis multiplex (HP:0000943) | 3.90034897 |
10 | Hypobetalipoproteinemia (HP:0003563) | 3.89552785 |
11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.78006381 |
12 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.78006381 |
13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.78006381 |
14 | Abnormality of methionine metabolism (HP:0010901) | 3.65185982 |
15 | Mucopolysacchariduria (HP:0008155) | 3.58953281 |
16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.58953281 |
17 | Complement deficiency (HP:0004431) | 3.58944982 |
18 | Obstructive sleep apnea (HP:0002870) | 3.54329384 |
19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.50470840 |
20 | Ketosis (HP:0001946) | 3.39179363 |
21 | Fat malabsorption (HP:0002630) | 3.37510806 |
22 | Hyperammonemia (HP:0001987) | 3.26902188 |
23 | Conjugated hyperbilirubinemia (HP:0002908) | 3.22010325 |
24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.18056979 |
25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16347569 |
26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15728104 |
27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15728104 |
28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15728104 |
29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.15609517 |
30 | Joint stiffness (HP:0001387) | 3.04627058 |
31 | Vascular calcification (HP:0004934) | 3.01994567 |
32 | Steatorrhea (HP:0002570) | 2.97817655 |
33 | Spontaneous hematomas (HP:0007420) | 2.95958621 |
34 | Dicarboxylic aciduria (HP:0003215) | 2.94397779 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94397779 |
36 | Hypoglycemic coma (HP:0001325) | 2.93883661 |
37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.93619458 |
38 | Abnormality of glycine metabolism (HP:0010895) | 2.93619458 |
39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.92790064 |
40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91845894 |
41 | Hyperglycinemia (HP:0002154) | 2.90230779 |
42 | Protrusio acetabuli (HP:0003179) | 2.88140233 |
43 | Cervical subluxation (HP:0003308) | 2.88009935 |
44 | Epidermoid cyst (HP:0200040) | 2.87398646 |
45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.85036735 |
46 | J-shaped sella turcica (HP:0002680) | 2.83472592 |
47 | Cerebral aneurysm (HP:0004944) | 2.79749043 |
48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79587383 |
49 | Hypolipoproteinemia (HP:0010981) | 2.76843135 |
50 | Stridor (HP:0010307) | 2.75017544 |
51 | Petechiae (HP:0000967) | 2.69073793 |
52 | Cerebral edema (HP:0002181) | 2.68848819 |
53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65534422 |
54 | Abnormality of glycolysis (HP:0004366) | 2.65198023 |
55 | Increased serum pyruvate (HP:0003542) | 2.65198023 |
56 | Flared iliac wings (HP:0002869) | 2.64845375 |
57 | Hyperglycinuria (HP:0003108) | 2.64722265 |
58 | Fragile skin (HP:0001030) | 2.64156363 |
59 | Generalized aminoaciduria (HP:0002909) | 2.62470355 |
60 | Cardiovascular calcification (HP:0011915) | 2.62459209 |
61 | Abnormality of serum amino acid levels (HP:0003112) | 2.61555042 |
62 | Opisthotonus (HP:0002179) | 2.60615597 |
63 | Spastic paraparesis (HP:0002313) | 2.60291090 |
64 | Parakeratosis (HP:0001036) | 2.56254942 |
65 | Supranuclear gaze palsy (HP:0000605) | 2.52938429 |
66 | Myositis (HP:0100614) | 2.51918078 |
67 | Thin bony cortex (HP:0002753) | 2.51608298 |
68 | Biconcave vertebral bodies (HP:0004586) | 2.48213954 |
69 | Abnormality of complement system (HP:0005339) | 2.48047276 |
70 | Lymphangioma (HP:0100764) | 2.45106168 |
71 | Distal upper limb amyotrophy (HP:0007149) | 2.43285258 |
72 | Upper limb amyotrophy (HP:0009129) | 2.43285258 |
73 | Interstitial pulmonary disease (HP:0006530) | 2.42193865 |
74 | Hypercholesterolemia (HP:0003124) | 2.41797385 |
75 | Metabolic acidosis (HP:0001942) | 2.41495976 |
76 | Mitral stenosis (HP:0001718) | 2.39900189 |
77 | Loss of speech (HP:0002371) | 2.39543366 |
78 | Broad metatarsal (HP:0001783) | 2.39212459 |
79 | Neurofibrillary tangles (HP:0002185) | 2.37053039 |
80 | Visceral angiomatosis (HP:0100761) | 2.36600820 |
81 | Hyperacusis (HP:0010780) | 2.35708221 |
82 | Systemic lupus erythematosus (HP:0002725) | 2.35162702 |
83 | Delayed CNS myelination (HP:0002188) | 2.34997994 |
84 | Premature rupture of membranes (HP:0001788) | 2.34867613 |
85 | Eczematoid dermatitis (HP:0000976) | 2.34638593 |
86 | Hepatic necrosis (HP:0002605) | 2.33997893 |
87 | Lethargy (HP:0001254) | 2.33989650 |
88 | Hypoalphalipoproteinemia (HP:0003233) | 2.33619270 |
89 | Papilledema (HP:0001085) | 2.33053792 |
90 | Cholecystitis (HP:0001082) | 2.31933907 |
91 | Abnormal gallbladder physiology (HP:0012438) | 2.31933907 |
92 | Hyperbilirubinemia (HP:0002904) | 2.31852163 |
93 | Mesangial abnormality (HP:0001966) | 2.29577064 |
94 | Colitis (HP:0002583) | 2.28543804 |
95 | Myocardial infarction (HP:0001658) | 2.28116516 |
96 | Renal cortical cysts (HP:0000803) | 2.24256713 |
97 | Ketoacidosis (HP:0001993) | 2.23874707 |
98 | Mitral regurgitation (HP:0001653) | 2.23628362 |
99 | Acute encephalopathy (HP:0006846) | 2.21009870 |
100 | Axonal loss (HP:0003447) | 2.20592467 |
101 | Abnormality of urine glucose concentration (HP:0011016) | 2.19666588 |
102 | Glycosuria (HP:0003076) | 2.19666588 |
103 | Hypoglycemic seizures (HP:0002173) | 2.17126920 |
104 | Disproportionate tall stature (HP:0001519) | 2.16101784 |
105 | Ovoid vertebral bodies (HP:0003300) | 2.15565910 |
106 | Paraparesis (HP:0002385) | 2.14950773 |
107 | Abnormal gallbladder morphology (HP:0012437) | 2.14814382 |
108 | Renal Fanconi syndrome (HP:0001994) | 2.14237923 |
109 | Amyloidosis (HP:0011034) | 2.13531739 |
110 | Methylmalonic acidemia (HP:0002912) | 2.13044111 |
111 | Increased cerebral lipofuscin (HP:0011813) | 2.12176012 |
112 | Vomiting (HP:0002013) | 2.11976160 |
113 | Neuronal loss in central nervous system (HP:0002529) | 2.11405147 |
114 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10524886 |
115 | Thoracic kyphosis (HP:0002942) | 2.09578257 |
116 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07438919 |
117 | Hypoplasia of the odontoid process (HP:0003311) | 2.06739251 |
118 | Aortic regurgitation (HP:0001659) | 2.05962941 |
119 | Hypophosphatemic rickets (HP:0004912) | 2.05532674 |
120 | Hemangiomatosis (HP:0007461) | 2.04608497 |
121 | Hand muscle atrophy (HP:0009130) | 2.04004997 |
122 | Purpura (HP:0000979) | 2.03522117 |
123 | Pancreatitis (HP:0001733) | 2.03049387 |
124 | Vacuolated lymphocytes (HP:0001922) | 2.02980205 |
125 | Ankle clonus (HP:0011448) | 2.00230601 |
126 | Reduced antithrombin III activity (HP:0001976) | 1.99147522 |
127 | Annular pancreas (HP:0001734) | 1.99056509 |
128 | Shallow orbits (HP:0000586) | 1.98736935 |
129 | Gingival bleeding (HP:0000225) | 1.98156851 |
130 | Atelectasis (HP:0100750) | 1.98091390 |
131 | Broad face (HP:0000283) | 1.97608578 |
132 | Bladder diverticulum (HP:0000015) | 1.96472468 |
133 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.96439160 |
134 | Enlarged kidneys (HP:0000105) | 1.95478058 |
135 | Hepatocellular necrosis (HP:0001404) | 1.94832003 |
136 | Spinal canal stenosis (HP:0003416) | 1.94558473 |
137 | Methylmalonic aciduria (HP:0012120) | 1.93563862 |
138 | Difficulty climbing stairs (HP:0003551) | 1.93528422 |
139 | Abnormality of the odontoid process (HP:0003310) | 1.93326536 |
140 | Increased IgE level (HP:0003212) | 1.92309323 |
141 | Glomerulonephritis (HP:0000099) | 1.91224340 |
142 | Vertebral compression fractures (HP:0002953) | 1.90942912 |
143 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.89769760 |
144 | Alkalosis (HP:0001948) | 1.89325764 |
145 | Elevated hepatic transaminases (HP:0002910) | 1.87610168 |
146 | Turricephaly (HP:0000262) | 1.86721955 |
147 | Easy fatigability (HP:0003388) | 1.85440145 |
148 | Cholelithiasis (HP:0001081) | 1.83261700 |
149 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.83027325 |
150 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.83027325 |
151 | Peripheral hypomyelination (HP:0007182) | 1.82282639 |
152 | Hepatocellular carcinoma (HP:0001402) | 1.81813669 |
153 | Proximal tubulopathy (HP:0000114) | 1.81712192 |
154 | Abnormality of the nasal mucosa (HP:0000433) | 1.81436270 |
155 | Deformed sella turcica (HP:0002681) | 1.81214517 |
156 | Pustule (HP:0200039) | 1.80988314 |
157 | White forelock (HP:0002211) | 1.80940919 |
158 | Patchy hypopigmentation of hair (HP:0011365) | 1.80329850 |
159 | Aneurysm (HP:0002617) | 1.80297528 |
160 | Anomalous pulmonary venous return (HP:0010772) | 1.80201367 |
161 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79981781 |
162 | Hemorrhage of the eye (HP:0011885) | 1.79412387 |
163 | Elevated alkaline phosphatase (HP:0003155) | 1.79029553 |
164 | Abnormality of purine metabolism (HP:0004352) | 1.78391167 |
165 | Genu recurvatum (HP:0002816) | 1.78195484 |
166 | Bulbar palsy (HP:0001283) | 1.77903529 |
167 | Skin nodule (HP:0200036) | 1.77712931 |
168 | Orchitis (HP:0100796) | 1.77708265 |
169 | Vitreoretinal degeneration (HP:0000655) | 1.76091828 |
170 | Abnormality of the gallbladder (HP:0005264) | 1.74936703 |
171 | Emphysema (HP:0002097) | 1.74054358 |
172 | Irritability (HP:0000737) | 1.73525940 |
173 | Abnormality of the thoracic spine (HP:0100711) | 1.73120986 |
174 | Nuclear cataract (HP:0100018) | 1.72280348 |
175 | Symptomatic seizures (HP:0011145) | 1.72157756 |
176 | Peritonitis (HP:0002586) | 1.71796999 |
177 | Short femoral neck (HP:0100864) | 1.70753473 |
178 | Abnormality of dentin (HP:0010299) | 1.70338024 |
179 | Esophageal varix (HP:0002040) | 1.68196734 |
180 | Broad distal phalanx of finger (HP:0009836) | 1.67573133 |
181 | Blue sclerae (HP:0000592) | 1.67281496 |
182 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67260037 |
183 | Diplopia (HP:0000651) | 1.67124312 |
184 | Abnormality of binocular vision (HP:0011514) | 1.67124312 |
185 | Pointed chin (HP:0000307) | 1.66716038 |
186 | Abnormal eating behavior (HP:0100738) | 1.66185253 |
187 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.65939446 |
188 | Hemoptysis (HP:0002105) | 1.65755150 |
189 | Hypertriglyceridemia (HP:0002155) | 1.65512152 |
190 | Pulmonary embolism (HP:0002204) | 1.64869467 |
191 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.64672363 |
192 | Lumbar hyperlordosis (HP:0002938) | 1.64118645 |
193 | Gastrointestinal inflammation (HP:0004386) | 1.63535381 |
194 | Ulnar bowing (HP:0003031) | 1.63488983 |
195 | Aortic aneurysm (HP:0004942) | 1.63370758 |
196 | Pulmonary artery stenosis (HP:0004415) | 1.63284625 |
197 | Gingivitis (HP:0000230) | 1.62846061 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 3.96387296 |
2 | STK39 | 3.77291587 |
3 | TRIB3 | 3.38664259 |
4 | INSRR | 2.88997658 |
5 | EPHB1 | 2.88394527 |
6 | SIK2 | 2.48388797 |
7 | OXSR1 | 2.45885925 |
8 | WNK4 | 2.28796339 |
9 | MAP3K14 | 2.23379360 |
10 | TAOK3 | 2.19607496 |
11 | MAP3K11 | 2.14636730 |
12 | PKN2 | 2.12573044 |
13 | TNIK | 2.08927149 |
14 | PBK | 2.05697420 |
15 | PKN1 | 2.02273457 |
16 | ERN1 | 1.96354020 |
17 | PIK3CG | 1.90331931 |
18 | MAPK15 | 1.89838165 |
19 | STK16 | 1.78839420 |
20 | SIK1 | 1.75916224 |
21 | IRAK3 | 1.70341148 |
22 | GRK6 | 1.68625707 |
23 | BMPR1B | 1.59540786 |
24 | BCR | 1.58048609 |
25 | RIPK1 | 1.57751940 |
26 | MET | 1.56013295 |
27 | MARK2 | 1.51491307 |
28 | SMG1 | 1.50965867 |
29 | PRPF4B | 1.47711014 |
30 | OBSCN | 1.46289701 |
31 | PRKD2 | 1.45717330 |
32 | ICK | 1.42924748 |
33 | PRKD3 | 1.39194128 |
34 | MAP3K3 | 1.38916111 |
35 | CDC42BPA | 1.38863271 |
36 | MUSK | 1.34398912 |
37 | ZAP70 | 1.30331939 |
38 | IRAK4 | 1.30214255 |
39 | ADRBK2 | 1.29431054 |
40 | ERBB4 | 1.29051712 |
41 | DDR2 | 1.28777373 |
42 | NTRK3 | 1.26430211 |
43 | TESK1 | 1.25026531 |
44 | CASK | 1.20815922 |
45 | BTK | 1.17391987 |
46 | IKBKE | 1.17167782 |
47 | SGK494 | 1.14308522 |
48 | SGK223 | 1.14308522 |
49 | SIK3 | 1.14169960 |
50 | PRKCQ | 1.13809535 |
51 | NTRK2 | 1.13102767 |
52 | PINK1 | 1.11340593 |
53 | MAP3K1 | 1.09859218 |
54 | TBK1 | 1.09548091 |
55 | GRK1 | 1.09133497 |
56 | MAPKAPK5 | 1.08776200 |
57 | KIT | 1.08194088 |
58 | GRK7 | 1.07638565 |
59 | FGFR4 | 1.07436062 |
60 | IRAK1 | 1.05125168 |
61 | ZAK | 1.04511924 |
62 | TEC | 1.04353590 |
63 | NUAK1 | 1.03672924 |
64 | MST1R | 1.01506381 |
65 | DYRK1B | 0.99227125 |
66 | RPS6KA2 | 0.98976832 |
67 | TESK2 | 0.97592660 |
68 | PAK6 | 0.97344691 |
69 | CAMKK1 | 0.97033317 |
70 | MAP3K13 | 0.95653052 |
71 | FES | 0.95491570 |
72 | TXK | 0.93141469 |
73 | DAPK2 | 0.90387132 |
74 | CAMK2D | 0.89940063 |
75 | IRAK2 | 0.88359912 |
76 | ITK | 0.87647179 |
77 | CAMK2G | 0.86979105 |
78 | MYLK | 0.84609381 |
79 | IKBKB | 0.82807690 |
80 | HIPK2 | 0.80279123 |
81 | PTK6 | 0.80232748 |
82 | CAMK1G | 0.79180300 |
83 | TAOK1 | 0.79073524 |
84 | MAP3K6 | 0.77734875 |
85 | MAP3K7 | 0.76872428 |
86 | FGFR2 | 0.76805847 |
87 | TYK2 | 0.76151368 |
88 | PRKAA2 | 0.76054747 |
89 | RET | 0.75825183 |
90 | CSK | 0.75531406 |
91 | MAP2K2 | 0.72795585 |
92 | NTRK1 | 0.72077354 |
93 | WNK1 | 0.71682805 |
94 | PDGFRA | 0.70664401 |
95 | HCK | 0.70186144 |
96 | BMX | 0.69993545 |
97 | PRKCE | 0.68347435 |
98 | TIE1 | 0.68207660 |
99 | CDK9 | 0.68021185 |
100 | MAP4K1 | 0.67424453 |
101 | CSNK1G3 | 0.67153703 |
102 | EIF2AK2 | 0.66728035 |
103 | TAOK2 | 0.66182704 |
104 | LYN | 0.64426499 |
105 | CDK19 | 0.64403667 |
106 | CSF1R | 0.63680112 |
107 | CSNK1A1L | 0.63505008 |
108 | CLK1 | 0.61603652 |
109 | CAMK2B | 0.61529851 |
110 | CSNK1G1 | 0.60773803 |
111 | STK38 | 0.59899666 |
112 | PTK2B | 0.59698153 |
113 | JAK3 | 0.59653169 |
114 | BLK | 0.59165490 |
115 | TRPM7 | 0.58534594 |
116 | SGK2 | 0.58284041 |
117 | TGFBR2 | 0.57399273 |
118 | MAPK7 | 0.57085207 |
119 | RPS6KL1 | 0.56793174 |
120 | RPS6KC1 | 0.56793174 |
121 | TYRO3 | 0.56136448 |
122 | MAPK11 | 0.56013832 |
123 | LMTK2 | 0.55735537 |
124 | MARK1 | 0.55492698 |
125 | FGR | 0.54125931 |
126 | CDK5 | 0.54123116 |
127 | ABL2 | 0.53837157 |
128 | MAPK12 | 0.52489997 |
129 | SYK | 0.51049428 |
130 | PRKCH | 0.50701275 |
131 | FLT3 | 0.48553639 |
132 | NEK6 | 0.48359632 |
133 | CAMK2A | 0.48063820 |
134 | JAK2 | 0.47855503 |
135 | FYN | 0.47837254 |
136 | NEK9 | 0.47828979 |
137 | YES1 | 0.47584520 |
138 | JAK1 | 0.46176507 |
139 | RPS6KA6 | 0.45665740 |
140 | PIK3CA | 0.45355000 |
141 | MTOR | 0.44963458 |
142 | TTN | 0.44802447 |
143 | TNK2 | 0.44421775 |
144 | LCK | 0.43756732 |
145 | ARAF | 0.42535468 |
146 | PDPK1 | 0.42501357 |
147 | PIM2 | 0.42106034 |
148 | GSK3A | 0.41578034 |
149 | KSR2 | 0.40667558 |
150 | PRKACA | 0.39395042 |
151 | EPHA3 | 0.39365233 |
152 | CAMK1 | 0.38210309 |
153 | PDK1 | 0.38145522 |
154 | BRAF | 0.37657679 |
155 | IGF1R | 0.36706268 |
156 | PRKD1 | 0.36239321 |
157 | LRRK2 | 0.36193586 |
158 | MAP2K3 | 0.35851308 |
159 | ABL1 | 0.35424539 |
160 | PRKG1 | 0.35102093 |
161 | MAP2K4 | 0.34945305 |
162 | CHUK | 0.33621050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.71198410 |
2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.05598367 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.87885731 |
4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.77859569 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.70316815 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63887691 |
7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.63421354 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46330912 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40208365 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39919214 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35623676 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27488171 |
13 | Peroxisome_Homo sapiens_hsa04146 | 2.25220325 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20413936 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15598826 |
16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14620719 |
17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.13119158 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09172667 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06981051 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02233348 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01910148 |
22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89161604 |
23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88240436 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85180400 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82692783 |
26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.79253702 |
27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76310671 |
28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75517556 |
29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.73717964 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69420912 |
31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69124955 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68928663 |
33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68602827 |
34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64202689 |
35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55306152 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44589619 |
37 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.42102566 |
38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40229387 |
39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39808265 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39314258 |
41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38145943 |
42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37608384 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36232661 |
44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34840448 |
45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.33538661 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31004388 |
47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30002614 |
48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26386902 |
49 | Protein export_Homo sapiens_hsa03060 | 1.24030815 |
50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21496703 |
51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18999391 |
52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18287868 |
53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16894365 |
54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15908494 |
55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13204959 |
56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13103232 |
57 | ABC transporters_Homo sapiens_hsa02010 | 1.12468971 |
58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12331860 |
59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11904187 |
60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11154216 |
61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10409278 |
62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10002461 |
63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05594674 |
64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05360001 |
65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05284559 |
66 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05105025 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04815246 |
68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03332945 |
69 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02549837 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02321283 |
71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99676684 |
72 | Morphine addiction_Homo sapiens_hsa05032 | 0.99604323 |
73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98910714 |
74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98448469 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.96285880 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95712605 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92356910 |
78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90644659 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89722423 |
80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89638445 |
81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89143884 |
82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88477546 |
83 | Bile secretion_Homo sapiens_hsa04976 | 0.88445492 |
84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87725996 |
85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87099368 |
86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85659516 |
87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85210257 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84789248 |
89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84777548 |
90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82812997 |
91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82377208 |
92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80571396 |
93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80553301 |
94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79404860 |
95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79122326 |
96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78572209 |
97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78201159 |
98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76958073 |
99 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74527535 |
100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74329098 |
101 | Pertussis_Homo sapiens_hsa05133 | 0.74201386 |
102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74019552 |
103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73685275 |
104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72648349 |
105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72234344 |
106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72157246 |
107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71963412 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71084674 |
109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.68647145 |
110 | Tuberculosis_Homo sapiens_hsa05152 | 0.68220893 |
111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67960603 |
112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66024909 |
113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64989644 |
114 | Glioma_Homo sapiens_hsa05214 | 0.63799007 |
115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63715294 |
116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62849761 |
117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62735350 |
118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61436979 |
119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61289586 |
120 | Lysine degradation_Homo sapiens_hsa00310 | 0.61210651 |
121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61190160 |
122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60745683 |
123 | Insulin resistance_Homo sapiens_hsa04931 | 0.60489254 |
124 | Salivary secretion_Homo sapiens_hsa04970 | 0.60093182 |
125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59549755 |
126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57722826 |
127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57691778 |
128 | Bladder cancer_Homo sapiens_hsa05219 | 0.57042770 |
129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56971098 |
130 | Hepatitis C_Homo sapiens_hsa05160 | 0.56605366 |
131 | Hepatitis B_Homo sapiens_hsa05161 | 0.56549169 |
132 | Axon guidance_Homo sapiens_hsa04360 | 0.55953792 |
133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55904132 |
134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55538926 |
135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55032399 |
136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54333655 |
137 | Insulin secretion_Homo sapiens_hsa04911 | 0.54008227 |
138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53246433 |
139 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53057369 |
140 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52982290 |
141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52890541 |
142 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51879037 |
143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51715237 |
144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50995996 |
145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50756138 |
146 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50471678 |
147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50110358 |
148 | Focal adhesion_Homo sapiens_hsa04510 | 0.50031996 |
149 | Nicotine addiction_Homo sapiens_hsa05033 | 0.49869582 |
150 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49565603 |
151 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49215509 |
152 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49145478 |
153 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49122560 |
154 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48950245 |
155 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44832085 |
156 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42221187 |
157 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39010352 |
158 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31510075 |
159 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30269119 |
160 | Lysosome_Homo sapiens_hsa04142 | 0.28922623 |
161 | Malaria_Homo sapiens_hsa05144 | 0.28384387 |
162 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27817118 |
163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20394169 |
164 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19189285 |
165 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16847828 |
166 | Huntingtons disease_Homo sapiens_hsa05016 | 0.16265132 |
167 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13886962 |
168 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12741479 |
169 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11616493 |
170 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.09596871 |
171 | Prion diseases_Homo sapiens_hsa05020 | 0.08138287 |
172 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07799323 |
173 | Galactose metabolism_Homo sapiens_hsa00052 | 0.05659960 |
174 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05623878 |
175 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03677175 |
176 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03088078 |
177 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.02394021 |
178 | Phagosome_Homo sapiens_hsa04145 | 0.02020756 |
179 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.01687600 |